Birch Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-439
Closed -$472K 140
2025
Q4
$472K Sell
439
-986
-69% -$943K 0.27% 73
2025
Q3
$1.09M Buy
1,425
+227
+19% +$169K 0.64% 32
2025
Q2
$934K Buy
1,198
+66
+6% +$51.3K 0.75% 31
2025
Q1
$935K Buy
1,132
+560
+98% +$466K 0.83% 25
2024
Q4
$442K Buy
+572
New +$474K 0.5% 44

Other funds holding LLY

Birch Financial Group's LLY Position: Q1 2026 in Review

Birch Financial Group sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 439 shares — an estimated $472K sold.

Birch Financial Group first reported a position in LLY in Q4 2024 and held it in 5 quarters. The position peaked at $1.09M in Q3 2025. 4,363 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Birch Financial Group reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Birch Financial Group sold 439 Eli Lilly shares in Q1 2026, an estimated $472K.
  • Birch Financial Group first reported a position in Eli Lilly in Q4 2024 and held it in 5 quarters.
  • Birch Financial Group's Eli Lilly position peaked at $1.09M in Q3 2025.
  • 4,363 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Birch Financial Group's 13F filing for Q1 2026, filed 17 Apr 2026.